Hao Zheng

2.1k total citations · 2 hit papers
46 papers, 1.2k citations indexed

About

Hao Zheng is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Hao Zheng has authored 46 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 14 papers in Pulmonary and Respiratory Medicine and 10 papers in Cancer Research. Recurrent topics in Hao Zheng's work include Ferroptosis and cancer prognosis (14 papers), Autophagy in Disease and Therapy (6 papers) and Angiogenesis and VEGF in Cancer (5 papers). Hao Zheng is often cited by papers focused on Ferroptosis and cancer prognosis (14 papers), Autophagy in Disease and Therapy (6 papers) and Angiogenesis and VEGF in Cancer (5 papers). Hao Zheng collaborates with scholars based in China, Japan and United States. Hao Zheng's co-authors include Shinya Toyokuni, Li Jiang, Fuyu Qiu, Yashiro Motooka, Guosheng Fu, Lian‐Wen Qi, Izumi Yanatori, Tsuyoshi Tsuduki, Marcus Conrad and Yan Chen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and ACS Nano.

In The Last Decade

Hao Zheng

42 papers receiving 1.2k citations

Hit Papers

Dynamic O-GlcNAcylation coordinates ferritinophagy and mi... 2022 2026 2023 2024 2022 2025 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hao Zheng China 19 786 375 370 127 102 46 1.2k
Yi Yu China 12 584 0.7× 355 0.9× 297 0.8× 67 0.5× 117 1.1× 33 1.1k
Mengqi Guo China 16 885 1.1× 504 1.3× 472 1.3× 95 0.7× 165 1.6× 34 1.4k
Zhanyu Wang China 10 611 0.8× 502 1.3× 434 1.2× 109 0.9× 74 0.7× 14 1.0k
Dongcheng Feng China 14 795 1.0× 527 1.4× 625 1.7× 238 1.9× 96 0.9× 22 1.4k
Yidong Yang China 18 635 0.8× 342 0.9× 483 1.3× 236 1.9× 128 1.3× 45 1.2k
Shanzhong Tan China 19 738 0.9× 435 1.2× 423 1.1× 431 3.4× 96 0.9× 40 1.4k
Jianhua Zhu China 18 595 0.8× 116 0.3× 349 0.9× 93 0.7× 187 1.8× 27 1.3k
Fanglin Niu China 11 425 0.5× 326 0.9× 305 0.8× 61 0.5× 112 1.1× 38 882
Zhaowei Wen China 8 752 1.0× 249 0.7× 500 1.4× 138 1.1× 81 0.8× 10 1.1k

Countries citing papers authored by Hao Zheng

Since Specialization
Citations

This map shows the geographic impact of Hao Zheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hao Zheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hao Zheng more than expected).

Fields of papers citing papers by Hao Zheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hao Zheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hao Zheng. The network helps show where Hao Zheng may publish in the future.

Co-authorship network of co-authors of Hao Zheng

This figure shows the co-authorship network connecting the top 25 collaborators of Hao Zheng. A scholar is included among the top collaborators of Hao Zheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hao Zheng. Hao Zheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Zhi‐Xuan, Hao Zheng, Dongli Li, et al.. (2025). Puerarin-rich compound Puerariae lobatae formulas alleviate hyperuricemia in mice by enhancing renal and intestinal function through regulating gut microbiota. Phytomedicine. 146. 157115–157115. 1 indexed citations
2.
Zheng, Hao, Shuwei Liu, Hao Jin, et al.. (2025). Synchronously Evoking Disulfidptosis and Ferroptosis via Systematical Glucose Deprivation Targeting SLC7A11/GSH/GPX4 Antioxidant Axis. ACS Nano. 19(14). 14233–14248. 20 indexed citations breakdown →
4.
Shimizu, Hideyuki, Hiroshi Tanaka, Akira Tazaki, et al.. (2024). Silicone oil, an intraocular surgical adjuvant, induces retinal ferroptosis. Free Radical Biology and Medicine. 228. 33–43.
5.
Zheng, Hao, et al.. (2024). Multifunctional DNA Nanoflower Applied for High Specific Photodynamic Cancer Therapy In Vivo. ChemBioChem. 25(13). e202400229–e202400229.
6.
Chen, Jinhua, Chunlei Wang, Feilong Zhou, et al.. (2024). An oncolytic HSV-1 armed with Visfatin enhances antitumor effects by remodeling tumor microenvironment against murine pancreatic cancer. Biochemical and Biophysical Research Communications. 718. 149931–149931. 5 indexed citations
7.
Yang, Zhuo, Xiaoyan Wang, Wenjuan Shen, et al.. (2024). Folic acids promote in vitro maturation of bovine oocytes by inhibition of ferroptosis via upregulated glutathione and downregulated Fe2+ accumulation. Animal Reproduction Science. 270. 107605–107605. 1 indexed citations
8.
Hao, Caili, et al.. (2024). Deficiency in glutathione peroxidase 4 (GPX4) results in abnormal lens development and newborn cataract. Proceedings of the National Academy of Sciences. 121(48). e2407842121–e2407842121. 5 indexed citations
9.
Zheng, Hao, et al.. (2023). A Mulberry Diels-Alder-Type Adduct, Kuwanon M, Triggers Apoptosis and Paraptosis of Lung Cancer Cells through Inducing Endoplasmic Reticulum Stress. International Journal of Molecular Sciences. 24(2). 1015–1015. 15 indexed citations
10.
Tazaki, Akira, Yoshihiko Usui, Atsunobu Takeda, et al.. (2023). Retinal ferroptosis as a critical mechanism for the induction of retinochoroiditis during ocular toxoplasmosis. Redox Biology. 67. 102890–102890. 8 indexed citations
11.
San, Emily Van, Yulia Y. Tyurina, Vladimir A. Tyurin, et al.. (2023). Ferroptosis contributes to multiple sclerosis and its pharmacological targeting suppresses experimental disease progression. Cell Death and Differentiation. 30(9). 2092–2103. 52 indexed citations
12.
Zheng, Hao, Qingying Liu, Shuqi Wang, et al.. (2022). Epimedokoreanin B inhibits the growth of lung cancer cells through endoplasmic reticulum stress-mediated paraptosis accompanied by autophagosome accumulation. Chemico-Biological Interactions. 366. 110125–110125. 22 indexed citations
13.
Luo, Yaguang, Shinya Akatsuka, Yashiro Motooka, et al.. (2022). BRCA1 haploinsufficiency impairs iron metabolism to promote chrysotile‐induced mesothelioma via ferroptosis resistance. Cancer Science. 114(4). 1423–1436. 7 indexed citations
14.
Miyata, Kenichi, Tze Mun Loo, Aki Hanyu, et al.. (2022). Hepatocyte growth factor derived from senescent cells attenuates cell competition-induced apical elimination of oncogenic cells. Nature Communications. 13(1). 4157–4157. 20 indexed citations
15.
Akatsuka, Shinya, Yashiro Motooka, Hao Zheng, et al.. (2022). BRCA1 haploinsufficiency promotes chromosomal amplification under Fenton reaction-based carcinogenesis through ferroptosis-resistance. Redox Biology. 54. 102356–102356. 21 indexed citations
16.
Zheng, Hao, Li Jiang, Tsuyoshi Tsuduki, Marcus Conrad, & Shinya Toyokuni. (2021). Embryonal erythropoiesis and aging exploit ferroptosis. Redox Biology. 48. 102175–102175. 74 indexed citations
17.
Wang, Jinxia, Xiaoqing Liu, Hao Zheng, et al.. (2020). Morusin induces apoptosis and autophagy via JNK, ERK and PI3K/Akt signaling in human lung carcinoma cells. Chemico-Biological Interactions. 331. 109279–109279. 43 indexed citations
18.
Chen, Qi, Yu Liu, Xueyan Ding, et al.. (2019). Bone marrow mesenchymal stem cell-secreted exosomes carrying microRNA-125b protect against myocardial ischemia reperfusion injury via targeting SIRT7. Molecular and Cellular Biochemistry. 465(1-2). 103–114. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026